Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan · Delayed Price · Currency is TWD 30.55
-0.10 (-0.33%)
Feb 11, 2026, 1:35 PM CST
Sinphar Pharmaceutical Market Cap
Sinphar Pharmaceutical has a market cap or net worth of 5.81 billion as of February 11, 2026. Its market cap has increased by 4.66% in one year.
Market Cap
5.81B
Enterprise Value
6.75B
Revenue
3.35B
Ranking
n/a
PE Ratio
16.88
Stock Price
30.55
Market Cap Chart
Since April 23, 2003, Sinphar Pharmaceutical's market cap has increased from 1.13B to 5.81B, an increase of 416.31%. That is a compound annual growth rate of 7.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 5.83B | 0.49% |
| Dec 31, 2025 | 5.80B | 2.64% |
| Dec 31, 2024 | 5.65B | -0.75% |
| Dec 29, 2023 | 5.69B | 2.41% |
| Dec 30, 2022 | 5.56B | 14.71% |
| Dec 30, 2021 | 4.85B | -6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 7.09B |
| OBI Pharma | 6.19B |
| Savior Lifetec | 6.07B |
| CHO Pharma | 5.74B |
| Locus Cell | 5.60B |
| Pharmosa Biopharm | 5.48B |
| Panion & Bf Biotech | 5.30B |
| UnicoCell Biomed | 5.22B |